Regulatory Q&A Forum
Ask questions, share knowledge, and get help from the regulatory community
With significant updates to Waste Electrical and Electronic Equipment (WEEE) and Extended Producer Responsibility (EPR) regulations anticipated for 2026 across the EU, UK, and various US states, how s...
With potential new global biocompatibility standards being discussed for 2026, which may not be immediately adopted by the FDA, how can medical device manufacturers develop a robust and defensible bio...
How can medical device manufacturers perform due diligence to select a biocompatibility testing laboratory that is prepared for evolving international standards, such as future updates to the ISO 1099...
What are the core requirements for a UK Responsible Person (UKRP) as Great Britain’s medical device regulations continue to evolve? For medical device manufacturers based outside the UK, appointing a...
With the UK's post-Brexit regulatory framework for medical devices continuing to evolve, what are the key responsibilities and strategic considerations for manufacturers when appointing and managing a...
When budgeting for an EU Responsible Person (RP) to meet cosmetic compliance deadlines, what key factors and service models determine the overall cost? Rather than a single fixed price, the investment...
When developing a novel Class II in vitro diagnostic (IVD) device that utilizes an AI/ML algorithm to aid in risk assessment or prognosis, what are the intersecting regulatory expectations for both th...
When medical device manufacturers plan to place electrical or electronic products on the European market, establishing compliance with the Waste Electrical and Electronic Equipment (WEEE) Directive an...
For manufacturers of medical devices also classified as Electrical and Electronic Equipment (EEE), navigating environmental compliance schemes like WEEE (Waste Electrical and Electronic Equipment) and...
While sponsors often seek a direct figure for biocompatibility testing costs, isn't the more critical question about understanding the variables that drive the total investment? For example, how does ...
Given that a fixed price for biocompatibility testing is not feasible without a specific device and its materials, what is a comprehensive framework for how sponsors can strategically budget for and m...
When selecting a UK Responsible Person (UKRP) for placing a medical device on the Great Britain market, how can a non-UK manufacturer move beyond a basic compliance check and conduct a thorough due di...
For non-UK medical device manufacturers, appointing a UK Responsible Person (UKRP) is a mandatory step for placing devices on the Great Britain market. While a common question revolves around the annu...
When a medical device manufacturer based outside the European Union intends to place a product on the EU market, they must appoint an EU Authorised Representative (EUAR). This is a mandatory legal rol...
What are Class II Special Controls and how do they impact the 510(k) submission process for a medical device? In the U.S. FDA’s risk-based classification system, Class II devices are those with a mod...
When a medical device manufacturer without a physical presence in a key market like the European Union needs to appoint an Authorized Representative, evaluating the associated costs involves more than...
For non-EU companies processing the personal data of EU residents, appointing a GDPR Article 27 Representative is often a mandatory requirement. While the service appears straightforward, the costs ca...
As global standards like ISO 10993-1 evolve towards a 2026 horizon, how can manufacturers effectively pivot from a historical, checklist-driven biocompatibility testing model to a more integrated, ris...
With significant updates to international consensus standards for biological evaluation on the horizon, how should medical device manufacturers strategically vet and select a biocompatibility testing ...
For a non-UK based medical device manufacturer preparing for UK market access, selecting a UK Responsible Person (UKRP) is a critical compliance step. Beyond simply having a registered address in Grea...